31.07.2017
Merck and Acino signed a distribution agreement
Acino will commercialize present 9 Merck products for the treatment of cardiovascular and endocrine diseases in Ukraine, Armenia, Azerbaijan, Kazakhstan,...
News
03.07.2017
Acino acquires Litha Healthcare
Acino has acquired South Africa’s Litha Healthcare. Litha, headquartered in Johannesburg, provides services and products to public and private hospitals,...
28.02.2017
Acino to acquire Litha Healthcare in South Africa
Acino signed a deal with certain subsidiaries of Endo International plc to acquire Litha Healthcare in South Africa. Litha Healthcare,...
15.02.2017
Appointment of Mario Ricard as COO and member of the Executive Committee
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
23.01.2017
Resignation of Barthold Piening, Chief Operations Officer
Barthold Piening, Chief Operations Officer and Member of the Executive Committee, has decided to leave Acino by mid of this...
30.11.2016
Acino closes the deal to divest its patch business to Luye Pharma Group Ltd.
On November 30, 2016, Acino International AG and Acino Pharma AG (together “Acino”) closed the deal with Luye Pharma Group...
01.11.2016
Acino closes the deal to acquire packaging plant in Põlva
Following the announcement of Acino and Takeda that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia, the closing of...
31.10.2016
Acino launches its new corporate brand identity
Acino is very pleased to launch today its new corporate brand identity and its new website under the URL www.acino.swiss.The new...
25.07.2016
Acino divests its patch business to Luye Pharma Group Ltd.
Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd....